No abstract

Non-diphtheritic corynebacteria are potential nosocomial pathogens among acute/chronic complicated skin and soft tissue infection. Vancomycin or linezolid can be used empirically to treat such infections until the invitro susceptibility results are available.

Introduction: Carbapenemase production is the most common mechanism of carbapenem resistance. The carbapenemases belongs to class A, class B and class D of Ambler's molecular classification. Various tests have been designed for screening and confirmation of these enzymes. The acidimetric based Carba NP (Nordmann Poirel) test is simple and detects carbapenemases within two hours. The test could not differentiate between the serine carbapenemases from Metallo β-Lactamase (MBL). Differentiation of these two classes of enzymes will help in choosing the newer carbapenemase inhibitors like avibactam which selectively act on serine carbapenemases. Aim: To design a test that can simultaneously confirm and differentiate Amblers class A and D from class B carbapenemase enzymes among clinical strains of the Gram-Negative Bacteria (GNB). Materials and Methods: An experimental study was conducted between January-December 2018 on 195 strains of carbapenem resistant and 40 strains of carbapenem sensitive GNB. The carbapenemase genes were detected among all the bacteria by multiplex Polymerase Chain Reaction (PCR). The Carba M test was designed and evaluated for the detection and differentiation of class A and D from class B carbapenemases among the study isolates. Results: The Carba M test had 100% sensitivity and specificity for identification of New Delhi Metallo-β-lactamase (NDM) and Verona Integron-encoded Metallo-β-lactamase (VIM) enzymes. The strains which co-produced two MBL enzymes were detected with 100% sensitivity. The test had 42.85% sensitivity for the detection of Oxacillinase (OXA)-48-like enzymes. Conclusion: The Carba M test is useful in detection and simultaneous differentiation of carbapenemase content of the GNB and will help to choose appropriate carbapenemase inhibitors judiciously

We present an on chip optofluidic surface deformable liquid Dove prism (LDP) based low‐fluid flow pressure monitoring device. The unique design of the device in combination with liquid and soft solid enabled by the total internal reflection of light makes the sensor highly sensitive and compatible with the integration of a microfluidic and/or Lab‐on‐a‐chip device. A layer‐by‐layer soft lithographic (LSL) and 3D printing technique are exploited to make the device. We have used Polydimethylsiloxane (PDMS) as the layer material and two variety of liquids (a) immersion oil (IO) and (b) di‐iodomethane (DI) as refracting medium to construct the LDP sensor. Optical ray tracing simulation is performed to optimize the sensor. The pressure sensor shows sensitivity as high as ±28.5 mV per 50 Pa pressure with an error ± 2.5 mV and repeatability of ~99.56% at full scale. We have shown the applicability of the sensor by capturing and analyzing respiratory pressure signals of some human subjects at numerous conditions.

Objective This article assesses the effectiveness of captopril, tetracycline, and ciprofloxacin as metallo-β-lactamase (MBL) inhibitors against New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli. Materials and Methods Twenty-four well-characterized carbapenem-resistant E. coli isolates which produced NDM (n = 21) and Oxa-48-like enzymes (n = 3) were used to assess the inhibitors. The positive control organism was designed by cloning the NDM gene into pET-24a plasmid and transforming it into expression vector E. coli BL21. All the proposed inhibitors were assessed for their interaction with MBLs using checkerboard minimum inhibitory concentration (MIC) assay with imipenem and meropenem. The fractional inhibitory concentration (FIC) index was calculated to assess the activity of molecules. Results The E. coli BL21 (DE3) pET-24a-bla NDM showed carbapenem resistance upon isopropyl β-D-1-thiogalactopyranoside induction and had MIC of 32 µg/mL for both imipenem and meropenem. For the test isolates, ∑FIC values of imipenem and meropenem with ethylenediaminetetraacetic acid (EDTA) ranged from 0.039 to 0.266 and 0.023 to 0.156, respectively. At a 256 µg/mL concentration, captopril had ∑FIC index value for imipenem and meropenem as 0.133 to 0.375 and 0.133 to 0.188, respectively. The tetracycline and ciprofloxacin in combination with meropenem/imipenem showed indifferent results. Conclusion Among the three molecules tested, captopril had MBL inhibitory activity, but the concentration required for inhibition was beyond the therapeutic safety levels. Ciprofloxacin and tetracycline had weak or no MBL inhibitory activity. Checkerboard MIC of EDTA with carbapenem antibiotic and control organism with NDM enzyme production helped us create a reference system for comparing and assessing the results of potential MBL inhibitors in future.